<DOC>
	<DOC>NCT00867971</DOC>
	<brief_summary>Recombinant growth hormone is a common therapy in the pediatric population. A number of associated side effects have been described. Several years ago, a case report was published concerning a child that was treated with RGH and developed acute glaucoma. To date no study has evaluated the connection.</brief_summary>
	<brief_title>Is Recombinant Growth Hormone Therapy Associated With Increased Intraoccular Pressure?</brief_title>
	<detailed_description />
	<criteria>Age 618 years treatment with recombinant growth hormone Underlying Chronic diseases Family history of eye diseases elevated occular pressure prior to starting treatment</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>February 2009</verification_date>
</DOC>